Crosslead
Payments companies reported to CMS as associated with Crosslead. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Crosslead, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Crosslead
These are the largest totals companies reported as associated with Crosslead. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Prakash Krishnan | New York, NY | Interventional Cardiology | $14,775.95 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $12,965.38 |
| Margaret Mcentegart | New York, NY | Interventional Cardiology | $12,950.92 |
| Craig Walker | Houma, LA | Interventional Cardiology | $524.91 |
| Eric Dippel | Davenport, IA | Interventional Cardiology | $457.22 |
| Miguel Montero | Houston, TX | Vascular & Interventional Radiology | $166.52 |
| Sean Lyden | Cleveland, OH | Vascular Surgery | $35.04 |
Prescribed Crosslead?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.